NASDAQ | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is designed to provide exposure toU. S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 7.45% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 7.39% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 7.15% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 6.91% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 6.25% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.91% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.75% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.65% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.62% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.60% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.41% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.02% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.98% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 2.42% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 2.35% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 2.12% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.01% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 1.92% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 1.89% |